Search results
5 days ago · 290,000 (2019) [4] Hepatitis C is an infectious disease caused by the hepatitis C virus (HCV) that primarily affects the liver; [2] it is a type of viral hepatitis. [6] During the initial infection period, people often have mild or no symptoms. [1] Early symptoms can include fever, dark urine, abdominal pain, and yellow tinged skin. [1]
3 days ago · As mentioned, anyone can get hepatitis C. However, some people are at a higher risk due to certain factors. These include: Intravenous (IV) drug use: Sharing needles and other equipment used for injecting drugs greatly increases the risk of contracting HCV. Blood transfusions or organ transplants before 1992: Prior to this time, no screening ...
18 hours ago · Join Virginia IMPACT as we dig deeper into the management of Hepatitis C with Infectious Disease Specialist and Clinician-Researcher Rebecca Dillingham MD, M...
- 63 min
- Virginia IMPACT Project ECHO Webinars
1 day ago · Hepatitis C can be passed from person to person through unprotected sexual contact or exposure to contaminated blood or needles—whether through drug use, tattoos or body piercing. When left untreated, hepatitis C can lead to severe liver damage, cirrhosis of the liver and liver cancer.
- 111 East 210th Street, Bronx, 10467, NY
1 day ago · Target Audience and Goal Statement. This activity is intended for healthcare professionals (HCPs) who treat, care for, and/or support patients with hepatitis C virus (HCV) infection, including primary care clinicians, nurses and nurse practitioners (NPs), and pharmacists and for patients with hepatitis C and their caregivers.
5 days ago · 1. Pathophysiology. HCV, an RNA virus of the Flaviviridae family, infects hepatocytes and evades the immune system, causing oxidative stress, inflammation and fibrosis, which can progress to cirrhosis, hepatic decompensation, HCC, and death. 1. Epidemiology.
Upon completion of this activity, participants should be able to: Assess both current and novel diagnostic and therapeutic protocols as they relate to managing the patient with hepatitis C and its complications. Identify parameters predictive of disease progression and response to therapy, including discrete patient populations.
